Schneiderman Daniel H 4
4 · Pasithea Therapeutics Corp. · Filed Oct 12, 2022
Insider Transaction Report
Form 4
Schneiderman Daniel H
Chief Financial Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-10-11+300,000→ 300,000 totalExercise: $1.26From: 2023-10-11Exp: 2032-10-11→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 300,000 stock options. The stock options have a ten-year term and vest over three years, subject to Mr. Schneiderman remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches monthly for two years thereinafter.